Long-term rapamycin treatment suppresses IL-17-producing gamma delta T cells and blunts neuroinflammation in aging
Clement Torrent, Caterina Gagliardi, Nina Fülle, Ignazio Antignano, Maria Eugenia Bernis, Miriam Stork, Daniele Bano, Melania Capasso · 2026
Read Long-term rapamycin treatment suppresses IL-17-producing gamma delta T cells and blunts neuroinflammation in aging by Clement Torrent, Caterina Gagliardi, Nina Fülle, Ignazio Antignano, Maria Eugenia Bernis, Miriam Stork, Daniele Bano, Melania Capasso (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0343183.txt.
Description
Clement Torrent, Melania Capasso, and co-authors fed aging mice low-dose rapamycin, a transplant drug that extends lifespan in many species, to see exactly which immune changes it causes in old age. Worry persists that a proven immune suppressant is a risky anti-aging bet. Their 2026 study profiled immune cells across tissues after long treatment, then challenged the animals with a bacterial trigger of inflammation.
Most immune populations, including the brain's resident microglia, barely changed. What did shrink was the age-related buildup of a specific T cell type that produces an inflammatory signal, especially around the abdomen. After the challenge, that signal ran lower in treated animals and their brain immune cells stayed calmer. The authors describe a narrow, targeted effect rather than broad suppression.
Catalog record
| CREATOR | Clement Torrent, Caterina Gagliardi, Nina Fülle, Ignazio Antignano, Maria Eugenia Bernis, Miriam Stork, Daniele Bano, Melania Capasso |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38241 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |